Oragenics (OGEN) Prepaid Assets (2010 - 2026)
Oragenics' (OGEN) quarterly Prepaid Assets came in at $1.4 million in Q1 2026, up 208.58% YoY from $448033.0 in Q1 2025, and down 13.59% on a QoQ basis from $1.6 million in Q4 2025.
Oragenics (OGEN) Prepaid Assets (2010 - 2026) Analysis & Trends
Oragenics (OGEN) has 17 years of Prepaid Assets data on file, last reported at $1.4 million in Q1 2026.
- Quarterly Prepaid Assets rose 208.58% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 208.58% YoY) and the FY2025 annual result came in at $1.6 million, up 163.3% from the prior year.
- Prepaid Assets retreated to $1.4 million in Q1 2026, from $1.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $2.9 million in Q4 2022 to a low of $7500.0 in Q3 2023.
- A 5-year average of $1.3 million and a median of $1.3 million in 2025 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets sank 99.71% — and 2024, when it jumped 12823.92%.
- Tracing OGEN's Prepaid Assets over 5 years: stood at $2.9 million in 2022, then slumped by 86.65% to $382273.0 in 2023, then soared by 58.96% to $607670.0 in 2024, then surged by 163.3% to $1.6 million in 2025, then retreated by 13.59% to $1.4 million in 2026.
- The last three Prepaid Assets figures came in at $1.4 million (Q1 2026), $1.6 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Oragenics | 2.38 Mn | 2.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.63 Mn |
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 448,033.00 |
| Dec 31, 2024 | 607,670.00 |
| Sep 30, 2024 | 969,294.00 |
| Jun 30, 2024 | 270,334.00 |
| Mar 31, 2024 | 1.46 Mn |
| Dec 31, 2023 | 382,273.00 |
| Sep 30, 2023 | 7,500.00 |
| Jun 30, 2023 | 56,393.00 |
| Mar 31, 2023 | 2.54 Mn |
| Dec 31, 2022 | 2.86 Mn |
| Sep 30, 2022 | 2.57 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | 1.72 Mn |
| Dec 31, 2021 | 416,759.00 |
| Sep 30, 2021 | 586,519.00 |